In 2012, GlaxoSmithKline (GSK) agreed to pay $3 billion in what was then the largest healthcare fraud settlement in U.S. history. At Barrett Johnston, we highlight this case because it shows the incredible scale of misconduct that whistleblowers and federal investigators can uncover when they work together. The case centered on allegations that GSK engaged […]
GlaxoSmithKline $3 Billion Settlement (2012) Read More »
The healthcare industry has long been the primary target for False Claims Act (FCA) enforcement, with no other sector in close second place.Over the past year, the federal government has unveiled several new or revamped whistleblower programs, most notably the Department of Justice’s antitrust program, which we have previously written about. However, despite the expanded
The Healthcare Industry Remains the Largest Target for False Claims Act Enforcement Read More »
The Department of Justice’s Antitrust Division has launched its first-ever Whistleblower Rewards Program, working in tandem with the U.S. Postal Service (USPS) and Postal Inspection Service. Under this new program, individuals who provide credible information leading to successful antitrust prosecutions are eligible for awards between 15% and 30% of any criminal fines the government recovers,
Department of Justice Announces First-of-Its-Kind Antitrust Whistleblower Program Read More »
